# Dermal Cumulative Irritant Patch Study

> **NCT04064125** · PHASE1 · COMPLETED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** FMX-101

## Key facts

- **NCT ID:** NCT04064125
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2016-09-28
- **Final completion:** 2016-10-28
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04064125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04064125, "Dermal Cumulative Irritant Patch Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04064125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*